stage IV bladder cancer
Showing 1 - 25 of >10,000
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Not yet recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +31 more
- Diagnostic Laboratory Biomarker Analysis
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Bladder Cancer, Squamous Cell Carcinoma of the Bladder, Stage III Bladder Cancer Trial in Atlanta (3D conformal radiation
Terminated
- Bladder Cancer
- +4 more
- 3D conformal radiation therapy
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Feb 14, 2022
Addressing Barriers to Palliative Care Use in Bladder Cancer
Completed
- Muscle-Invasive Bladder Carcinoma
- +3 more
- Surveys
-
Tampa, FloridaMoffitt Cancer Center
Dec 30, 2022
Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,
Recruiting
- Bladder Carcinoma
- +7 more
- Atezolizumab
- +5 more
-
Toronto, Ontario, CanadaUniversity Health Network Princess Margaret Cancer Center LAO
Nov 8, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +41 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +13 more
- Pembrolizumab
- Propranolol Hydrochloride
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 8, 2022
Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,
Not yet recruiting
- Bladder Squamous Cell Carcinoma
- +10 more
- Biospecimen Collection
- +5 more
-
Atlanta, Georgia
- +3 more
Feb 20, 2023
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +18 more
- Enfortumab Vedotin
- Erdafitinib
-
Los Angeles, California
- +2 more
Jun 28, 2022
Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in
Recruiting
- Advanced Bladder Urothelial Carcinoma
- +23 more
- Atezolizumab
- +2 more
-
Riverside, California
- +8 more
Jul 16, 2022
Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder
Active, not recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +35 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +7 more
Jan 3, 2023
Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,
Recruiting
- Advanced Bladder Carcinoma
- +34 more
- Atezolizumab
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Blood and Tissue Samples From Locally Recurrent or Metastatic
Recruiting
- Localized Renal Pelvis and Ureter Urothelial Carcinoma
- +10 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 21, 2021
Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)
Not yet recruiting
- Melanoma
- Urothelial Carcinoma
-
Berlin, GermanyLocal Institution - 0001
Aug 9, 2022
Collecting Blood Samples From and Without Cancer to Evaluate
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +61 more
- Questionnaire Administration
- Biospecimen Collection
- (no location specified)
Apr 12, 2022
Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,
Active, not recruiting
- Hydronephrosis
- +18 more
- Durvalumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Bladder Urothelial
Not yet recruiting
- Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- Biospecimen Collection
- +7 more
- (no location specified)
Aug 10, 2023
Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma
Recruiting
- Bladder Small Cell Neuroendocrine Carcinoma
- +16 more
- Carboplatin
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022
Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,
Recruiting
- Distal Urethral Cancer
- +8 more
- afatinib dimaleate
- laboratory biomarker analysis
-
Atlanta, Georgia
- +5 more
Sep 24, 2021
Remote Telemonitoring of Patient-Generated Physiologic Health
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +171 more
- Patient Monitoring
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Bladder Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v8, Stage IVA Bladder Cancer AJCC v8 Trial in Los Angeles
Active, not recruiting
- Bladder Urothelial Carcinoma
- +3 more
- Durvalumab
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Dec 2, 2021
Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Breast Cancer Trial in United States (Behavioral Intervention)
Recruiting
- Stage II Breast Cancer
- +22 more
- Behavioral Intervention
-
Bay City, Michigan
- +7 more
Sep 29, 2021
Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma
Active, not recruiting
- Recurrent Malignant Solid Neoplasm
- +15 more
- Canady Helios Cold Plasma Scalpel
-
Washington, District of ColumbiaCanady Surgical Group PC
Jul 16, 2021
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,
Active, not recruiting
- Bladder Urothelial Carcinoma
- +4 more
- Biopsy
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States
Recruiting
- Invasive Ductal Breast Carcinoma
- +14 more
- Stereotactic body radiotherapy
- Lattice Radiation Therapy
-
Basking Ridge, New Jersey
- +6 more
Apr 20, 2023